- Home
- TCRX vs LTRX Comparison
TCRX vs LTRX Comparison
Compare TCRX & LTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- LTRX
- Stock Information
- Founded
- TCRX 2018
- LTRX 1989
- Country
- TCRX United States
- LTRX United States
- Employees
- TCRX N/A
- LTRX N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- LTRX Computer Communications Equipment
- Sector
- TCRX Health Care
- LTRX Telecommunications
- Exchange
- TCRX Nasdaq
- LTRX Nasdaq
- Market Cap
- TCRX 90.5M
- LTRX 106.5M
- IPO Year
- TCRX 2021
- LTRX 2000
- Fundamental
- Price
- TCRX $1.38
- LTRX $2.27
- Analyst Decision
- TCRX Strong Buy
- LTRX Strong Buy
- Analyst Count
- TCRX 7
- LTRX 5
- Target Price
- TCRX $9.86
- LTRX $5.80
- AVG Volume (30 Days)
- TCRX 396.8K
- LTRX 211.4K
- Earning Date
- TCRX 05-06-2025
- LTRX 05-08-2025
- Dividend Yield
- TCRX N/A
- LTRX N/A
- EPS Growth
- TCRX N/A
- LTRX N/A
- EPS
- TCRX N/A
- LTRX N/A
- Revenue
- TCRX $4,421,000.00
- LTRX $155,842,000.00
- Revenue This Year
- TCRX $47.30
- LTRX N/A
- Revenue Next Year
- TCRX $74.30
- LTRX $11.33
- P/E Ratio
- TCRX N/A
- LTRX N/A
- Revenue Growth
- TCRX N/A
- LTRX 12.96
- 52 Week Low
- TCRX $1.02
- LTRX $1.91
- 52 Week High
- TCRX $9.69
- LTRX $4.55
- Technical
- Relative Strength Index (RSI)
- TCRX 42.86
- LTRX 52.33
- Support Level
- TCRX $1.32
- LTRX $2.10
- Resistance Level
- TCRX $1.65
- LTRX $2.30
- Average True Range (ATR)
- TCRX 0.13
- LTRX 0.10
- MACD
- TCRX -0.01
- LTRX 0.04
- Stochastic Oscillator
- TCRX 14.63
- LTRX 90.63
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About LTRX Lantronix Inc.
Lantronix Inc is a networking company. It provides secure data access and management solutions for the Internet of Things (IoT) and information technology assets. It organizes its products and solutions into three product lines: Embedded IoT Solutions, IoT Systems Solutions, and Software and Services. The IoT System Solutions segment is the key revenue driver for the company. The company serves a diverse range of markets including healthcare, industrial, security, energy, transportation, and government networking. Its primary geographic markets are the Americas, Europe, the Middle East and Africa, and Asia Pacific Japan. The Americas contribute the vast majority of total revenue.